Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Modulating tumor blood vessels using nanostructures including nanoparticles, liposomes, micelles, polymers, and nanobiomaterials may potentially enhance the EPR effect for different cancer therapies, such as pancreatic cancer and ulcerative colitis.
“By modulating tumor blood vessels utilizing nanostructures including NPs, liposomes, micelles, polymers, and nanobiomaterials for drug delivery, the EPR effect may be potentially enhanced for different cancer therapies, such as pancreatic cancer and ulcerative colitis [14,16].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [14]
The citation lists haven’t been fetched yet
References 179 · Cited by 50
- Authors
- Mohammadzadeh, V., Rahiman, N., Hosseinikhah, S. M., Barani, M., Rahdar, A., Jaafari, M. R., Sargazi, S., Zirak, M. R., Pandey, S., Bhattacharjee, R., Gupta, A. K., Thakur, V. K., Sibuh, B. Z., & Gupta, P. K.
- Affiliations
- Mashhad University of Medical Sciences (IR)
- Kerman University of Medical Sciences (IR)
- Zabol University (IR)
- Zahedan University of Medical Sciences (IR)
- Yeungnam University (KR)
- KIIT University (IN)
- J.C. Bose University of Science & Technology, YMCA (IN)
- Scotland's Rural College (GB)
- Sharda University (IN)
- Graphic Era University (IN)
- Corresponding author
- Rahdar, Abbas
- Jaafari, Mahmoud Reza
- Gupta, Ashish Kumar
- Gupta, Piyush Kumar
- ORCID
- Venue
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 73
- Pages
- 103459
- ISSN
- 1773-2247 (ISSN-L)
- OpenAlex
- W4281565194
- Cited by
- 50
- References
- 179
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 12 · 2023: 11 · 2022: 7
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Drug Delivery Science and Technology (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- pancreatic cancer, enhanced permeability and retention effect, targeted drug delivery, tumor stroma, desmoplasia, angiogenesis modulation, tumor vasculature, liposomes, micelles, polymers, theranostics, tumor imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
